Business Services News

Business Services News

Breaking News on Business Services

Home > Business Services Search Engine                                 

Business Services News -- Video Feeds
  • Advertising
  • Careers
  • Corporate news
  • Economy
  • Markets
  • Small Business
  • Personal Finance
  • Regulatory and Compliance
  • Business News

    Alzheimers Disease Partnering 2010-2015 Market Analysis and Forecast Report
    (I-BusinessNews.Com, March 08, 2016 ) Alzheimers Disease Partnering 2010-2015 Size and Share Published in 2015-05-01 Available for US$ 1795 at


    The Alzheimer’s Disease Partnering 2010-2015 report provides understanding and access to the alzheimer’s disease partnering deals and agreements entered into by the worlds leading healthcare companies.

    Trends in alzheimer’s disease partnering deals

    Top alzheimer’s disease deals by value

    Deals listed by company A-Z, industry sector, stage of development, technology type

    The Alzheimer ’s Disease Partnering 2010-2015 provides understanding and access to the alzheimer’s disease partnering deals and agreements entered into by the worlds leading healthcare companies.

    The report provides an analysis of alzheimer’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors alzheimer’s disease technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

    Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

    This data driven report contains over 250 links to online copies of actual alzheimer’s disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

    Download Sample of this Report at:

    The initial chapters of this report provide an orientation of alzheimer’s disease partnering trends.

    Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

    Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

    Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

    Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

    In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of alzheimer’s disease technologies and products.

    Report scope

    Alzheimer’s Disease Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to alzheimer’s disease trends and structure of deals entered into by leading companies worldwide.

    This data driven report includes:

    Trends in alzheimer’s disease dealmaking in the biopharma industry since 2010

    Access to summary headline, upfront, milestone and royalty data

    Access to over 250 alzheimer’s disease deals

    The leading alzheimer’s disease deals by value since 2010

    In Alzheimer’s Disease Partnering 2010-2015, the available deals are listed by:

    Headline value

    Upfront payment value

    Royalty rate value

    Company A-Z

    Industry sector

    Stage of development at signing

    Deal component type

    Technology type

    Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

    Make an Enquiry:

    Table of Content

    Chapter 1 – Introduction

    Chapter 2 – Trends in alzheimer’s disease partnering

    2.1. Introduction

    2.2. Alzheimer’s disease partnering over the years

    2.3. Alzheimer’s disease partnering by deal type

    2.4. Alzheimer’s disease partnering industry sector

    2.5. Alzheimer’s disease partnering by stage of development

    2.6. Alzheimer’s disease partnering by technology type

    Chapter 3 – Average deal terms for alzheimer’s disease

    3.1 Introduction

    3.2 Average deal terms for alzheimer’s disease

    3.3 Alzheimer’s disease headline values with median calculation

    3.4 Alzheimer’s disease upfront values with median calculation

    3.5 Alzheimer’s disease milestone values with median calculation

    3.6 Alzheimer’s disease royalty rates with median calculation

    Browse All Diseases & Conditions Market Research Reports at

    About ResearchMoz

    ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

    Contact Us:

    Mr. Nachiket Ghumare, +1-518-621-2074
    USA-Canada Toll Free: 866-997-4948 <||>rn

    For More Report Click Here @

    Researchmoz Global Pvt.Ltd



    Source: EmailWire.Com


    Business News Feeds
  • Business News - Top Stories
  • Company Earnings
  • Economy
  • Personal Finance
  • Real Estate
  • Stock Markets
  • Business Services Sponsors

    Business Services Ads

    Business Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    CIO Insight
    Managed Healthcare Executive
    Mortgage Technology

    No credit cards, coupons, or promo codes required. Try it today!

    Press release service

    :: Home: :: Submit Press Release :: Subscribe to News :: Contact Us :: Help

    For unlimited press release distribution for $59 per month, call (281) 645-4086 or start posting your press releases online at

    Copyright 2008 GroupWeb Media LLC
    GroupWeb Media Network

    Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | | iT-NewsWire.Com
    | i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
    I-BusinessNews.Com is a business news service of GroupWeb Media LLC